respiratory
Cystic fibrosis

‘Window of opportunity’ for children with CF


A study exploring the use of the oral drug ivacaftor in very young children with a CFTR gating mutation suggests there may be a window in early life where at least partial restoration of pancreatic function might be possible. The open label single-arm study of 34 pre-school children with cystic fibrosis aged between 2 and ...

Already a member?

Enter your email to keep reading.


OR